Wednesday, March 12, 2014
Saturday, March 08, 2014
Quack Doc Watch: German Medical Board Issues Sweeping Findings in B...
Quack Doc Watch: German Medical Board Issues Sweeping Findings in B...: German Medical Board Issues Sweeping Findings in Boldt Case Ninety studies implicated in probe, might require retraction by Adam Marcus...
CollaGUARD adhesion barrier now in distributed in UK and Germany
01 Feb, 2012
ASHBURN, VA., February 1, 2012 /PRNewswire/ –– Innocoll Inc. announced it has entered into a License and Distribution Agreement with Flynn Pharma Ltd. in the United Kingdom and with Inresa Arzneimittel GmbH in Germany for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.
Breaking News Seprafilm Genzyme
Attorney General J.B. Van Hollen Announces Settlement with Genzyme Corporation to Resolve Allegations of Off-Label Marketing
March 07, 2014
Email
Print
Free Newsletter
| Targeted News Service |
Attorney General J.B. Van Hollen announced today that Wisconsin has joined with other states and the federal government to settle allegations thatGenzyme Corp. (Genzyme ) marketed and caused false claims to be submitted to federal and state health care programs for use of a "slurry" version of its Seprafilm adhesion barrier. Seprafilm is a thin film intended to reduce adhesions after surgery by forming a bio-resorbable barrier between abdominal tissue and organs. Genzyme is a biotechnology corporation based in Cambridge, Mass. , and was acquired by Sanofi-Aventis SA in April 2011 . As part of the settlement, Wisconsin Medicaid will receive $44,698.27 in restitution and other recoveries. Medicaid is a health insurance program for the needy and disabled jointly funded by the state and federal governments. The agreement resolves allegations that Genzyme sales representatives taught doctors and other staff to cut the Seprafilm sheets into small pieces, add saline and allow the pieces to dissolve until the desired consistency was reached. This mixture was referred to as "slurry." Genzyme sales representatives traded recipes for slurry, and trained each other in how to create it. The slurry was used in laparoscopic surgeries by inserting a catheter filled with the mixture into the body and applying it into the abdominal cavity. Seprafilm isFDA -approved for use in open abdominal surgery but not for minimally invasive surgeries, such as laparoscopic surgery. Allegedly, as a result of this conduct,Genzyme knowingly caused hospitals and other purchasers of Seprafilm to submit false and fraudulent claims to health care programs for uses that were not reimbursable.
TNS 30FurigayJof 140307-4659904 30FurigayJof
| Copyright: | (c) 2014 Targeted News Service |
| Wordcount: | 276 http://insurancenewsnet.com/oarticle/2014/03/07/attorney-general-jb-van-hollen-announces-settlement-with-genzyme-corporation-t-a-470833.html#.Uxr7pPldWHg |
Should women with chronic pelvic pain have adhesiolysis?
Pelvic adhesions are found in up to 50% of women with CPP during investigative surgeries and adhesiolysis is often performed as part of their management although the causal or casual association of adhesions, and the clinical benefit of adhesiolysis in the context of CPP is still unclear. Our aim was to test the hypothesis of whether laparoscopic adhesiolysis leads to significant pain relief and improvement in quality of life (QoL) in patients with chronic pelvic pain (CPP) and adhesions.
Methods: This was a double-blinded RCT.
This study was conducted in 2 tertiary referral hospitals in United Kingdom over 4 years. Women with chronic pelvic pain (CPP) were randomized into having laparoscopic adhesiolysis or diagnostic laparoscopy.
Women were assessed at 0, 3 and 6 months for Visual analogue scale scores (VAS) and Quality of Life (QoL) measures (SF-12 and EHP-30).
Results: A total of 92 participants were recruited; 50 qualified to be randomized, with 26 in the adhesiolysis and 24 in the control group. The results are expressed in median (interquartile ranges).
In women who underwent adhesiolysis, there was a significant improvement at 6 months in VAS scores (-17.5 (-36.0 - -5.0) compared to controls (-1.5 (-15.0 - 4.5; p = 0.048); SF-12 scores physical component score (25.0 (18.8 - 43.8)) compared to controls (6.3 (-6.3 - 18.8); p = 0.021), SF-12 emotional component score 32.5 (4.4 - 48.8) compared to controls -5 (-21.3 - 15.0); p <0 -5="" -="" .0074="" 15.0="" 32.5="" 48.8="" and="" being="" compared="" controls="" domain="" ehp-30="" emotional="" nbsp="" p="" span="" the="" to="" well="">
Conclusions: This study stopped before recruitment reached the statistically powered sample size due to difficulty with enrollment and lack of continued funding. In selected population of women presenting to the gynecological clinic with chronic pelvic pain, adhesiolysis in those who have adhesions may be of benefit in terms of improvement of pain and their quality of life.Trial registration number: ISRCTN 43852269 http://www.controlled-trials.com/isrctn/pf/43852269
Author: Ying C CheongIsobel ReadingSarah BaileyKhaled SadekWilliam LedgerTin C Li
Credits/Source: BMC Women's Health 2014, 14:36
http://7thspace.com/headlines/453858/should_women_with_chronic_pelvic_pain_have_adhesiolysis.html
Methods: This was a double-blinded RCT.
This study was conducted in 2 tertiary referral hospitals in United Kingdom over 4 years. Women with chronic pelvic pain (CPP) were randomized into having laparoscopic adhesiolysis or diagnostic laparoscopy.
Women were assessed at 0, 3 and 6 months for Visual analogue scale scores (VAS) and Quality of Life (QoL) measures (SF-12 and EHP-30).
Results: A total of 92 participants were recruited; 50 qualified to be randomized, with 26 in the adhesiolysis and 24 in the control group. The results are expressed in median (interquartile ranges).
In women who underwent adhesiolysis, there was a significant improvement at 6 months in VAS scores (-17.5 (-36.0 - -5.0) compared to controls (-1.5 (-15.0 - 4.5; p = 0.048); SF-12 scores physical component score (25.0 (18.8 - 43.8)) compared to controls (6.3 (-6.3 - 18.8); p = 0.021), SF-12 emotional component score 32.5 (4.4 - 48.8) compared to controls -5 (-21.3 - 15.0); p <0 -5="" -="" .0074="" 15.0="" 32.5="" 48.8="" and="" being="" compared="" controls="" domain="" ehp-30="" emotional="" nbsp="" p="" span="" the="" to="" well="">
Conclusions: This study stopped before recruitment reached the statistically powered sample size due to difficulty with enrollment and lack of continued funding. In selected population of women presenting to the gynecological clinic with chronic pelvic pain, adhesiolysis in those who have adhesions may be of benefit in terms of improvement of pain and their quality of life.Trial registration number: ISRCTN 43852269 http://www.controlled-trials.com/isrctn/pf/43852269
Author: Ying C CheongIsobel ReadingSarah BaileyKhaled SadekWilliam LedgerTin C Li
Credits/Source: BMC Women's Health 2014, 14:36
http://7thspace.com/headlines/453858/should_women_with_chronic_pelvic_pain_have_adhesiolysis.html
Men get adhesions
Do Men Get Adhesions?
David Wiseman PhD, MRPharmS, Founder, International Adhesions Society
It is a common myth that only women are prone to adhesions. While it is
certainly true that women have more “internal parts” that require surgery, which
inevitably leads to adhesions, men are not excluded from the problem of
adhesions.
A simple look at the national statistics collected from hospital discharges (ICD9
codes) from the most recent data available (2001-2005) reveals the following:
• Over 50,000 men were discharged from hospital in 2005 with a diagnosis
of peritoneal adhesions (568.0), accounting for 28% of such diagnoses,
compared with 72% for women.
• Over 37,000 men were discharged in 2005 with a diagnosis that included
the specific diagnosis of intestinal adhesions with (ie causing) bowel
obstruction (560.81). This number accounts for 38% of cases, compared
with 62% for women.
• Men also accounted for 37% of discharges with a principal diagnosis (as
opposed to an incidental diagnosis) was intestinal adhesions with
obstruction (560.81). Their length of stay was slightly higher than that of
women in 3 of the five years studied and their hospital charges exceeded
those of women in every year by as much as $2500.
• Over 2000 men and women died every year with a diagnosis of intestinal
adhesions with obstruction, representing about 3% of the total discharges
with that diagnosis. The contribution of males to this death rate was in
every year slightly higher than that of women in proportion to their
discharges, by 10-15% in the years 2002-2005, and about 2% in 2001.
Overall discharges for men and women have been climbing at the same rate over
the five year period studied.
More of this article http://www.adhesionrelateddisorder.com/DoMenGetAdhesions.pdf
Wednesday, March 05, 2014
German Researchers Introduce Endo Gel Adhesion Barrier
German Researchers Introduce Endo Gel Adhesion Barrier
Perhaps this may help you make an informed decision in your struggles with Adhesion Related Disorder
BioScience GmbH
BioScience was established in 2005 in Germany by a team of researchers and experts with over three decades of experience in the medical industry We serve our customers with a wide range of products for surgeons, physicians, and other health care professionals. BioScience is strongly committed to product excellence and is proud to be registered ISO 13485:2003 .
BioScience was established in 2005 in Germany by a team of researchers and experts with over three decades of experience in the medical industry We serve our customers with a wide range of products for surgeons, physicians, and other health care professionals. BioScience is strongly committed to product excellence and is proud to be registered ISO 13485:2003 .
BioScience GmbH .
Rheinstrabe 96. D-56235 Ransbach-Baumbach. Telephone:  +49(0)2623 9709793FAX: +49(0) 2623 9709792 info@bio-science.org |
About Adhesion
In accordance to good surgical practice and preventing formation of post surgical adhesions it is recommended to use Hyacorp endo gel; which forms a physical barrier against the contact between adjacent tissues and remain on the site of application for seven days, which is sufficient to avoid the formation of adhesions during the critical healing process of injured tissues.
HYAcorp endo gel is a Bio-absorbable ,sterile , transparent, high viscous gel obtained by condensation of hyaluronic acid, one of the main components of human connective tissue and of epithelial and mesothelial tissues and it perfectly adheres to the tissue surface and to the abdominal wall creating an anti adhesion barrier.
In accordance to good surgical practice and preventing formation of post surgical adhesions it is recommended to use Hyacorp endo gel; which forms a physical barrier against the contact between adjacent tissues and remain on the site of application for seven days, which is sufficient to avoid the formation of adhesions during the critical healing process of injured tissues.
HYAcorp endo gel is a Bio-absorbable ,sterile , transparent, high viscous gel obtained by condensation of hyaluronic acid, one of the main components of human connective tissue and of epithelial and mesothelial tissues and it perfectly adheres to the tissue surface and to the abdominal wall creating an anti adhesion barrier.
Read More: http://www.hyacorp-endogel.com/index.html
Monday, March 03, 2014
Mark Grinstaff ~ Boston University Ground Breakers ~ Wish to cure adhesions
Mark Grinstaff flips quickly through his lecture slides, some showing honeycomb-like molecular structures, others equations and tables describing the properties of various compounds. Welcome to biomaterials class, a two-hour-long sally into the scholarly mysteries of chemistry and biomedical engineering, but one that is brought back to earth in purposeful discussions about the real-world applications of the science displayed on the screen."
“If you could figure out how to prevent all adhesions after surgery, it would be great,” says Grinstaff, a College of Arts & Sciences professor of chemistry, a College of Engineering professor of biomedical engineering, and a member of the ENG Division of Materials Science and Engineering. “I’d love to figure out how to do it.”
Read the rest here: http://www.bu.edu/today/2014/grinstaff-group-from-grad-students-to-groundbreakers
Mark Grinstaff ~ Boston University Ground Breakers ~ Wish to cure adhesions
“If you could figure out how to prevent all adhesions after surgery, it would be great,” says Grinstaff, a College of Arts & Sciences professor of chemistry, a College of Engineering professor of biomedical engineering, and a member of the ENG Division of Materials Science and Engineering. “I’d love to figure out how to do it.”
Read the rest here: http://www.bu.edu/today/2014/grinstaff-group-from-grad-students-to-groundbreakers
Mark Grinstaff ~ Boston University Ground Breakers ~ Wish to cure adhesions
Saturday, March 01, 2014
More from Dr Koya Mesh Failure & MESH TRAINING and REGULATION
More from Dr Koya Mesh Failure & MESH TRAINING and REGULATION
Hanifa B. Koya FRCOG, FRANZCOG
Gynaecologist
Wakefield Specialist Medical Centre
Wellington, New Zealand
21 March 2013
MESH TRAINING and REGULATION
"It has been estimated that 50% of women by the age of 50 years will have some degree of pelvic
organ prolapse (POP) and at least 10% by the age of 80 will require surgery. The vaginal
prolapse is classified as anterior, posterior and apical (vaginal vault). POP has always been
considered a difficult problem to manage and in a significant percentage of patients the prolapse
surgery has a tendency to fail.
The surgeons invariably felt that the failure was due to the poor quality of the patient’s tissues
and therefore looked for a substitute for conventional vaginal repair. A synthetic mesh therefore
seemed the ideal material to use. There are many different types of meshes used in POP
surgery (biological, absorbable synthetic, nonabsorbable and composite). Nearly all of the
meshes used for POP repairs are nonabsorbable synthetic i.e. lightweight monofilament
polypropylene. Ideal mesh properties for POP surgery should result in minimal infection,
minimal inflammatory reaction and avoidance of excessive fibrosis."
"If the Medical Profession and the Regulatory Board were ‘in control’, we would not be seeing so
much unhappiness and Class Action. The patients are generally suspicious of Industries
wanting to sell their products, but want to trust the Doctors and the Regulators. One cannot
regulate everything and credentialing retains a certain degree of trust. A further report was
released by the FDA in 2011 which said that “there were an enormous number of serious,
unique complications with use of vaginal mesh and that these cases were just the tip of
a looming iceberg.”
. " I wrote to Medsafe for three years regarding another product (Spray Gel) and really got nowhere. Medsafe informed me that they did not have all the jurisdiction and because we did not have
FDA, they could only take limited action."
Dr Hanifa Koya was the doctor who was instrumental in stopping Confluent's adhesion barrier Spray Gel after realizing it was actually causing more adhesions as she re-operated on patients who had Spray Gel ( now SparyShield ) instilled
Thank you Dr Koya for saving us!
Hanifa B. Koya FRCOG, FRANZCOG
Gynaecologist
Wakefield Specialist Medical Centre
Wellington, New Zealand
21 March 2013
MESH TRAINING and REGULATION
"It has been estimated that 50% of women by the age of 50 years will have some degree of pelvic
organ prolapse (POP) and at least 10% by the age of 80 will require surgery. The vaginal
prolapse is classified as anterior, posterior and apical (vaginal vault). POP has always been
considered a difficult problem to manage and in a significant percentage of patients the prolapse
surgery has a tendency to fail.
The surgeons invariably felt that the failure was due to the poor quality of the patient’s tissues
and therefore looked for a substitute for conventional vaginal repair. A synthetic mesh therefore
seemed the ideal material to use. There are many different types of meshes used in POP
surgery (biological, absorbable synthetic, nonabsorbable and composite). Nearly all of the
meshes used for POP repairs are nonabsorbable synthetic i.e. lightweight monofilament
polypropylene. Ideal mesh properties for POP surgery should result in minimal infection,
minimal inflammatory reaction and avoidance of excessive fibrosis."
"If the Medical Profession and the Regulatory Board were ‘in control’, we would not be seeing so
much unhappiness and Class Action. The patients are generally suspicious of Industries
wanting to sell their products, but want to trust the Doctors and the Regulators. One cannot
regulate everything and credentialing retains a certain degree of trust. A further report was
released by the FDA in 2011 which said that “there were an enormous number of serious,
unique complications with use of vaginal mesh and that these cases were just the tip of
a looming iceberg.”
. " I wrote to Medsafe for three years regarding another product (Spray Gel) and really got nowhere. Medsafe informed me that they did not have all the jurisdiction and because we did not have
FDA, they could only take limited action."
Thank you Dr Koya for saving us!
Abdominal cocoon: an unusual cause of subacute intestinal obstruction.
Indian J Surg. 2013 Jun;75(Suppl 1):391-3. doi: 10.1007/s12262-012-0582-9. Epub 2012 Sep 1.
Abdominal cocoon: an unusual cause of subacute intestinal obstruction.
Abstract
We report an unusual cause of subacute intestinal obstruction in a young adolescent girl, which is a nontubercular abdominal cocoon. Barium meal follow-through revealed "cauliflower"-like appearance of small bowel. The patient underwent an exploratory laparotomy showing thick fibrous-like coverings which were encasing the small bowel loops to form an abdominal cocoon. Fibrocollagenous membrane was excised after adhesiolysis. Histopathological examination of membrane revealed fibrocollagenous membrane with hyaline deposition of nontubercular origin.
KEYWORDS:
Abdominal cocoon, Sclerosing encapsulating peritonitis, Subacute intestinal obstruction
- PMID:
- 24426626
- [PubMed]
- PMCID:
- PMC3693371
- [Available on 2014/6/1]
Wednesday, February 26, 2014
Kruschiski toots his own horn with grandiose lies and self proclomations
"Doctor Daniel Kruschinski is a philathropist and humanitarian."
Don't fall for it ~ Stay safe and research his methods and TRY to find proof of his statistics. A paid for PR release does not make what is said below true in any way.
World's Most Reputable Doctor Lands Huge Cyber Deal | PRLog
PRLog (Press Release) - Feb. 3, 2014 - Dr. Kruschinski is one of the most highly respected doctors in the medical world. His specialty is gynecology and obstetrics but he also has a knack for giving free consultations and putting others before the monetary gain that most doctors usually go after.
Dr. Kruschinski is quickly becoming one of the most admired doctors in his practice today. He has performed live operations within different international locations all over the globe.
We spoke to one of his patients today, "Dr. Kruschinski makes you feel at ease. I was really nervous before the procedure and Dr. Kruschinski made me feel like I was safe. It's doctors like this who make it comfortable. He really took every effort to insure my wellness."
We recognize hard working doctors such as Daniel Kruschinski and his many good ties to the medical community. Dr. Daniel Kruschinski absolutely adores his medical practice. He's come a long way from his Polish roots to the self preserved top 100 doctors in Germany and now he sets his prize on the online market and helping others virally. Doctor Daniel Kruschinski is a philathropist and humanitarian.
Dr. Kruschinski is quickly becoming one of the most admired doctors in his practice today. He has performed live operations within different international locations all over the globe.
We spoke to one of his patients today, "Dr. Kruschinski makes you feel at ease. I was really nervous before the procedure and Dr. Kruschinski made me feel like I was safe. It's doctors like this who make it comfortable. He really took every effort to insure my wellness."
We recognize hard working doctors such as Daniel Kruschinski and his many good ties to the medical community. Dr. Daniel Kruschinski absolutely adores his medical practice. He's come a long way from his Polish roots to the self preserved top 100 doctors in Germany and now he sets his prize on the online market and helping others virally. Doctor Daniel Kruschinski is a philathropist and humanitarian.
--- End ---
Um some citations would help a person swallow this whopper a bit better but it kind of says it all the way it is ~ Quack
Abdominal Wall Lift ~ Beware the Abdolift
Beware of the Abdo-lift....
Abdominal wall lift decreases cardiopulmonary changes, does not influence the morbidity and, increases operating time in laparoscopic cholecystectomy. It cannot be recommended routinely
.Gurusamy KS, Samraj K, Davidson BR.Published Online: July 16, 2008.Several physiological parameters related to heart and lung (cardiopulmonary changes) occur during insufflation of abdomen (tummy) with key-hole surgery. While these changes can be tolerated by normal individuals, patients with poor heart or lung function may not tolerate the changes. These changes in physiological parameters related to heart and lung are decreased by using special instruments to lift the front wall of the abdomen so that key-hole surgery can be performed without gas insufflation. In this systematic review of 20 trials including 706 patients (six trials including 156 patients used gas at very low pressures), it is shown that the technique of lifting the front wall of the tummy is associated with increased operating time (8 minutes) without reducing surgical complications. It cannot be recommended as a routine in patients with mild or no systemic disease. So, it cannot be recommended routinely in patients with low anaesthetic risk.
http://summaries.cochrane.org/CD006574/abdominal-wall-lift-decreases-cardiopulmonary-changes-does-not-influence-the-morbidity-and-increases-operating-time-in-laparoscopic-cholecystectomy.-it-cannot-be-recommended-routinely
.Gurusamy KS, Samraj K, Davidson BR.Published Online: July 16, 2008.Several physiological parameters related to heart and lung (cardiopulmonary changes) occur during insufflation of abdomen (tummy) with key-hole surgery. While these changes can be tolerated by normal individuals, patients with poor heart or lung function may not tolerate the changes. These changes in physiological parameters related to heart and lung are decreased by using special instruments to lift the front wall of the abdomen so that key-hole surgery can be performed without gas insufflation. In this systematic review of 20 trials including 706 patients (six trials including 156 patients used gas at very low pressures), it is shown that the technique of lifting the front wall of the tummy is associated with increased operating time (8 minutes) without reducing surgical complications. It cannot be recommended as a routine in patients with mild or no systemic disease. So, it cannot be recommended routinely in patients with low anaesthetic risk.
http://summaries.cochrane.org/CD006574/abdominal-wall-lift-decreases-cardiopulmonary-changes-does-not-influence-the-morbidity-and-increases-operating-time-in-laparoscopic-cholecystectomy.-it-cannot-be-recommended-routinely
Where are Kruschinski's studies? Oh right there aren't any real ones, just vividly imagined ones.
Friday, February 21, 2014
Hutter Finally Rids himself of Kruschinski at Klinik am Zuckerberg
All signs of Kruschinski's existence has been eradicated from the Zuckerberg website....go see for yourself.
We are actually grateful as adhesion patients were having major abdominal surgeries at a day surgery plastic surgery type clinic..exceedingly dangerous
...perhaps you will be safer at Herzog but with Kru and his evil hook....we doubt it.
Hutter has hidden him here.
http://www.herzog-karl-klinik.de/gynaekologie/index.htm
Clinic after clinic after clinic.
We are actually grateful as adhesion patients were having major abdominal surgeries at a day surgery plastic surgery type clinic..exceedingly dangerous
...perhaps you will be safer at Herzog but with Kru and his evil hook....we doubt it.
Hutter has hidden him here.
http://www.herzog-karl-klinik.de/gynaekologie/index.htm
Clinic after clinic after clinic.
adhesiologicum.com DANGER New Name Same Scam Kruschinski and Steward Urber Cons ARD
ADHESIOLOGICUM!!!!!
A skunk by any other name still stinks.If it's too good to be true.....it is!
Now get a load of what appears to be a Karen Steward tutorial on how to beg and mooch money for Kruschinski......Shame on you.
http://adhesiologicum.com/raising-funds-for-adhesiologicum-germany
.jpg)
Kruschinski Steward Adhesion Whoppers
Found on a fundraising site for a poor young woman stricken with adhesion's. Poor dear thinks she needs $20 grand in cash to not die!
"Surgeons in the USA have only a 10% success rate. It's that bad because the F.D.A. has been dragging there feet in approving the materiel that has been successfully working for 13 years worth of surgeries in other parts of the world.
The doctor that I need to see is in Germany and he has a 95% success rate with adhesion surgery."
All of the above is stated to lure you to an all cash surgery IN GERMANY with Daniel Kruschinski. Con man extraordinaire.
THESES PEOPLE PREY ON THE MOST VULNERABLE PATIENT POPULATION EVER.
They will say anything to get you on that shoddy bandwagon.
The statements above don't have one grain of truth in them...not one. Go ahead and see if you can find any studies that state these luring proclamations.
Do you homework and verify all information yourself. We know you are sick but this is your life. There is help, there is hope and very close to where ever you live. Don't trust another to do your footwork for you ( Like Karen )
Thursday, January 30, 2014
Hernia and Adhesions Q&A from The Surgeons Lounge
"The patient presented to our clinic with complaints of nausea, vomiting and abdominal pain. The nausea and vomiting started in January 2012, a few months after the small bowel resection. It was noted that he was not able to tolerate a regular diet after surgery for an extended period of time. His physician prescribed metoclopramide without effect, and the nausea occurred three to four times weekly with vomiting at least once or twice per week. Eating sometimes exacerbated the nausea and vomiting. He also complained of intermittent bloating and abdominal distention."
Read the full question in full with answer and scans too...
http://www.generalsurgerynews.com/ViewArticle.aspx?d=The%2BSurgeon%27s%2BLounge&d_id=72&i=January+2014&i_id=1032&a_id=24814
Read the full question in full with answer and scans too...
http://www.generalsurgerynews.com/ViewArticle.aspx?d=The%2BSurgeon%27s%2BLounge&d_id=72&i=January+2014&i_id=1032&a_id=24814
Friday, January 03, 2014
Thursday, December 26, 2013
Teenager speaks out over medical condition that leaves her looking nine months pregnant every time she eats
Hey, wait a minute!
RACHEL Harley, 19, had to turn down a place at University in London because of her health after developing a bizarre condition that makes her stomach swell so much after eating that people think she's expecting.
http://www.dailyrecord.co.uk/news/real-life/teenager-speaks-out-over-medical-2880437
Teenager speaks out over medical condition that leaves her looking nine months pregnant every time she eats
RACHEL Harley, 19, had to turn down a place at University in London because of her health after developing a bizarre condition that makes her stomach swell so much after eating that people think she's expecting.
http://www.dailyrecord.co.uk/news/real-life/teenager-speaks-out-over-medical-2880437
Teenager speaks out over medical condition that leaves her looking nine months pregnant every time she eats
Subscribe to:
Posts (Atom)